Treatment with perilesional injections of pentoxifylline in patients with Peyronie's disease improves the therapeutic effect of oral and topical antioxidant therapy
To the Editor, We conducted a retrospective study to demonstrate that it is possible to achieve better therapeutic outcomes through combining perilesional injections of pentoxifylline (PTX) with oral antioxidants and the local application of a cream containing antioxidants and a gel containing dicl...
Saved in:
Main Authors: | Gianni Paulis, Andrea Paulis, Giovanni De Giorgio |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2025-02-01
|
Series: | Archivio Italiano di Urologia e Andrologia |
Subjects: | |
Online Access: | https://www.pagepressjournals.org/aiua/article/view/13525 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recent Pathophysiological Aspects of Peyronie’s Disease: Role of Free Radicals, Rationale, and Therapeutic Implications for Antioxidant Treatment—Literature Review
by: Gianni Paulis, et al.
Published: (2017-01-01) -
Pentoxifylline Prevents Autoimmune MediatedInflammation in Low Dose Streptozotocin InducedDiabetes
by: Stanislava D. Stošić-Grujičić, et al.
Published: (2001-01-01) -
Cost-effectiveness of oral versus injectable disease modifying therapies in relapsing multiple sclerosis: a systematic review analysis
by: Mehdi Rezaee, et al.
Published: (2024-10-01) -
Ailelerin Ateşe Yönelik Oral İlaç Uygulamalarının Geliştirilmesinde Hemşirenin Rolü
by: Duygu Gözen, et al.
Published: (2023-04-01) -
Multiple sclerosis: overview of orally administrated disease-modifying drugs. Do genetics influence the success of treatment?
by: A. Ovčinikova, et al.
Published: (2019-03-01)